Recent Posts
- MicroRNA-Mediated Metastasis Suppression
- A New Explanation Of ‘Asian Paradox’
- Toward Bold New Anti-cancer Medicines
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion’s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
- $6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research
Random Posts
- New Diet And Exercise Guidelines For Prostate Health Published By Prostate Cancer Foundation
- License From Saladax Biomedical Is Foundation Of New Molecular Oncology Test Launched By Myriad Genetics
- Gene Network Linked to Brain Tumor (CME/CE, with video)
- American Association For Cancer Research Opens Nominations For Susan G. Komen For The Cure(R) Award
- Patient Response To Therapy For Gastrointestinal Stromal Tumors May Be Predicted By Gene Signature
- Quality of Life Might Help Decide Between Prostate Cancer Therapies (CME/CE)
- Boehringer Ingelheim To Present New Phase II Clinical Data On Two Lead Oncology Compounds At ASCO 2009
- Home Interventions Could Benefit Cancer Survivors
- Can Kidney Disease Cause Cancer?
- New Therapy Option For Advanced HER2 Breast Cancer Approved In Canada
Prescription Cancer Drugs
Toward Bold New Anti-cancer Medicines
Posted by: admin in Prescription Cancer Drugs on November 07th, 2009
Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time, according to an article in the current issue of Chemical & Engineering News, ACS’ weekly newsmagazine.
C&EN Senior Editor Lisa Jarvis notes that “molecularly targeted” drugs are having a major impact in treating cancer of the breast, colon, and other body parts. Those medications interfere with specific molecules involved in cancer’s growth and spread. However, further advances are critical.
One new strategy involves cutting off cancer cells’ supply of blood sugar, or glucose, and thus starving them to death. Another uses RNA interference, a form of gene therapy in which short RNA segments serve as medication to block the genes involved in cancer. Although scientists face major hurdles in developing effective methods for administering RNA-based medicines, they are making rapid progress in doing so.
Source
Chemical & Engineering News
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.